JPRN-UMIN000018486
Completed
Phase 2
Phase II trial in treatment of gastrointestinal fistulas with endoscopic injection of an alpha-cyanoacrylate monomer - Phase II trial in treatment of gastrointestinal fistulas with endoscopic injection of an alpha-cyanoacrylate monomer
Second Department of Surgery, Wakayama Medical University, School of Medicine0 sites20 target enrollmentAugust 1, 2015
ConditionsGastrointetinal fistulas
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Gastrointetinal fistulas
- Sponsor
- Second Department of Surgery, Wakayama Medical University, School of Medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with esophagotracheal fistulas 2\) Patients with bile duct fistulas 3\) Patients with pancreatic duct fistulas 4\) Doctor's decision not to register to this regimen
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
Unknown
Not Applicable
Clinical trial treatment of intestinal failure and parenteral nutrition associated liver disease using an omega-3 fatty acid (fish oil) based intravenous fat emulsion, OMEGAVEintestinal failure and parenteral nutrition associated liver diseaseJPRN-UMIN000001914Tohoku University Hospital10
Active, not recruiting
Phase 2
TOP GEAR: Trial of Preoperative Therapy for Gastric and Esophagogastric Junction AdenocarcinomaA randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancerResectable Gastric CancerCancer - StomachACTRN12609000035224Australasian Gastro-Intestinal Trials Group (AGITG)574
Completed
Not Applicable
Study of EndoBarrier Liner for Treatment of Type 2 Diabetes StudyType 2 DiabetesNCT00986349Morphic Medical Inc.23
Completed
Not Applicable
Clinical trial on the incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin: a randamized control study using transnasal endoscopy in healthy volunteersupper gastrointestinal mucosal injuryJPRN-UMIN000001375Endoscopy Center, Tokyo Medical University Hospital40